68 related articles for article (PubMed ID: 9851439)
1. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
Lehky TJ; Levin MC; Kubota R; Bamford RN; Flerlage AN; Soldan SS; Leist TP; Xavier A; White JD; Brown M; Fleisher TA; Top LE; Light S; McFarland HF; Waldmann TA; Jacobson S
Ann Neurol; 1998 Dec; 44(6):942-7. PubMed ID: 9851439
[TBL] [Abstract][Full Text] [Related]
2. Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru.
Best I; Adaui V; Verdonck K; González E; Tipismana M; Clark D; Gotuzzo E; Vanham G
Clin Exp Immunol; 2006 Nov; 146(2):226-33. PubMed ID: 17034574
[TBL] [Abstract][Full Text] [Related]
3. Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based Series.
Meyerowitz EA; Mukerji SS; Kyle Harrold G; Erdil RM; Chen ST; Rudmann EA; Tsibris A; Venna N; Robbins GK
Clin Infect Dis; 2023 Sep; 77(6):851-856. PubMed ID: 37157862
[TBL] [Abstract][Full Text] [Related]
4. High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.
Goon PK; Igakura T; Hanon E; Mosley AJ; Asquith B; Gould KG; Taylor GP; Weber JN; Bangham CR
J Virol; 2003 Sep; 77(17):9716-22. PubMed ID: 12915584
[TBL] [Abstract][Full Text] [Related]
5. Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease.
Yamano Y; Takenouchi N; Li HC; Tomaru U; Yao K; Grant CW; Maric DA; Jacobson S
J Clin Invest; 2005 May; 115(5):1361-8. PubMed ID: 15864353
[TBL] [Abstract][Full Text] [Related]
6. Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy.
Sato T; Nagai M; Watanabe O; Misu T; Takenouchi N; Ohkubo R; Ishihara S; Tsuboi Y; Katsuno M; Nakagawa M; Matsushita T; Aso Y; Matsuura E; Tokashiki T; Mukaino A; Adachi H; Nakanishi K; Yamaguchi Y; Yamaguchi S; Yamano Y
J Neurol; 2024 Jun; 271(6):3471-3485. PubMed ID: 38430272
[TBL] [Abstract][Full Text] [Related]
7. EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls.
Monaco MCG; Soldan SS; Su C; Clauze A; Cooper JF; Patel RJ; Lu F; Hughes RJ; Messick TE; Andrada FC; Ohayon J; Lieberman PM; Jacobson S
Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37562974
[TBL] [Abstract][Full Text] [Related]
8. Effect of Teriflunomide on Cells From Patients With Human T-cell Lymphotropic Virus Type 1-Associated Neurologic Disease.
Enose-Akahata Y; Ngouth N; Ohayon J; Mandel M; Chavin J; Turner TJ; Jacobson S
Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33837058
[TBL] [Abstract][Full Text] [Related]
9. Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Enose-Akahata Y; Jacobson S
Retrovirology; 2019 Nov; 16(1):35. PubMed ID: 31783764
[TBL] [Abstract][Full Text] [Related]
10. IL-2 receptors preassemble and signal in the ER/Golgi causing resistance to antiproliferative anti-IL-2Rα therapies.
Volkó J; Kenesei Á; Zhang M; Várnai P; Mocsár G; Petrus MN; Jambrovics K; Balajthy Z; Müller G; Bodnár A; Tóth K; Waldmann TA; Vámosi G
Proc Natl Acad Sci U S A; 2019 Oct; 116(42):21120-21130. PubMed ID: 31570576
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial of a humanized anti-IL-2/IL-15 receptor β chain in HAM/TSP.
Enose-Akahata Y; Oh U; Ohayon J; Billioux BJ; Massoud R; Bryant BR; Vellucci A; Ngouth N; Cortese I; Waldmann TA; Jacobson S
Ann Clin Transl Neurol; 2019 Aug; 6(8):1383-1394. PubMed ID: 31402625
[TBL] [Abstract][Full Text] [Related]
12. Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis.
Nozuma S; Jacobson S
Front Microbiol; 2019; 10():885. PubMed ID: 31105674
[TBL] [Abstract][Full Text] [Related]
13. Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis.
Baldassari LE; Rose JW
Neurotherapeutics; 2017 Oct; 14(4):842-858. PubMed ID: 28707278
[TBL] [Abstract][Full Text] [Related]
14. Cytokine Therapies in Neurological Disease.
Azodi S; Jacobson S
Neurotherapeutics; 2016 Jul; 13(3):555-61. PubMed ID: 27388288
[TBL] [Abstract][Full Text] [Related]
15. Common γ-chain blocking peptide reduces in vitro immune activation markers in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Massoud R; Enose-Akahata Y; Tagaya Y; Azimi N; Basheer A; Jacobson S
Proc Natl Acad Sci U S A; 2015 Sep; 112(35):11030-5. PubMed ID: 26283355
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.
Milo R
Ther Adv Neurol Disord; 2014 Jan; 7(1):7-21. PubMed ID: 24409199
[TBL] [Abstract][Full Text] [Related]
17. Daclizumab therapy for multiple sclerosis.
Bielekova B
Neurotherapeutics; 2013 Jan; 10(1):55-67. PubMed ID: 23055048
[TBL] [Abstract][Full Text] [Related]
18. Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis.
Martin F; Castro H; Gabriel C; Adonis A; Fedina A; Harrison L; Brodnicki L; Demontis MA; Babiker AG; Weber JN; Bangham CR; Taylor GP
PLoS Negl Trop Dis; 2012; 6(6):e1675. PubMed ID: 22720101
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.
Gensicke H; Leppert D; Yaldizli Ö; Lindberg RL; Mehling M; Kappos L; Kuhle J
CNS Drugs; 2012 Jan; 26(1):11-37. PubMed ID: 22171583
[TBL] [Abstract][Full Text] [Related]
20. The NK cell as a new player in the pathogenesis of HTLV-I associated neurologic disease.
Jacobson S
Virulence; 2010; 1(1):8-9. PubMed ID: 21178408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
